Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma

G Jia, J Van Valkenburgh, AZ Chen… - Wiley …, 2022 - Wiley Online Library
Transarterial chemoembolization (TACE) is a recommended treatment for patients suffering
from intermediate and advanced hepatocellular carcinoma (HCC). As compared to the …

CIRSE standards of practice on hepatic transarterial chemoembolisation

P Lucatelli, M Burrel, B Guiu, G de Rubeis… - Cardiovascular and …, 2021 - Springer
Abstract This CIRSE Standards of Practice document is aimed at interventional radiologists
and provides best practices for performing transarterial chemoembolisation. It has been …

Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study

P Lucatelli, G De Rubeis, B Rocco, F Basilico… - BMC …, 2021 - Springer
Background To compare oncological results and safety profile of balloon micro-catheter
trans-arterial chemoembolization (b-TACE) and drug-eluting-microsphere (DEM-TACE) in …

In vivo comparison of micro-balloon interventions (MBI) advantage: a retrospective cohort study of DEB-TACE versus b-TACE and of SIRT versus b-SIRT

P Lucatelli, G De Rubeis, C Trobiani, S Ungania… - Cardiovascular and …, 2022 - Springer
Purpose The purpose of this study was to evaluate in vivo the role of the micro-balloon by
comparing trans-arterial chemoembolization (DEB-TACE) and selective internal …

[PDF][PDF] Durable complete response is achieved by balloon‐occluded transcatheter arterial chemoembolization for hepatocellular carcinoma

T Shirono, H Iwamoto, T Niizeki… - Hepatology …, 2022 - Wiley Online Library
In 2013 and 2014, the development of microcatheters with balloons for the 4‐Fr system and
new embolization materials provided various options for transarterial chemoembolization …

Surgical Resection Is Superior to TACE in the Treatment of HCC in a Well Selected Cohort of BCLC-B Elderly Patients—A Retrospective Observational Study

S Brozzetti, C D'Alterio, S Bini, J Antimi, B Rocco… - Cancers, 2022 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is the most common primary liver
malignancy. Liver transplantation (LT) and surgical resection (SR) are currently the primary …

Two-dimensional perfusion angiography permits direct visualization of redistribution of flow in hepatocellular carcinoma during b-TACE

P Lucatelli, S Ciaglia, B Rocco, G De Rubeis… - La radiologia …, 2024 - Springer
Objectives To demonstrate in vivo redistribution of the blood flow towards HCC's lesions by
utilizing two-dimensional perfusion angiography in b-TACE procedures. Material and …

[HTML][HTML] Comparison of liver function and safety in hepatocellular cancer patients treated with DEB-TACE and cTACE: a multi-center, retrospective cohort study

H Xiang, B Xiong, H Li, C Zhao, Z Zhang… - Translational Cancer …, 2019 - ncbi.nlm.nih.gov
Background This study aimed to compare the live function change and adverse events (AEs)
between drug-eluting beads (DEB) transarterial chemoembolization (TACE) with …

Unresectable hepatocellular carcinoma treatment with doxorubicin-eluting polyethylene glycol microspheres: a single-center experience

G Tovar-Felice, A García-Gámez… - Hepatic …, 2021 - Taylor & Francis
Background: Transarterial chemoembolization (TACE) is indicated for unresectable
hepatocellular carcinoma. Methods: This was a retrospective study of 50 hepatocellular …

Drug-Eluting Embolic TACE (DEB-TACE)

M Burrel, P Bermúdez - Transarterial Chemoembolization (TACE), 2023 - Springer
Drug-eluting microsphere transarterial chemoembolization (DEM-TACE) is a relatively new
intra-arterial treatment based on the use of microspheres to release chemotherapeutic …